Paper12802201
Assessing disease onset and progression in the SOD1 mouse model of ALS.
Weydt P and 3 others. Neuroreport, 2003. Cited by 192 papers, by iCite.
Cite this record
ConductScience Library. Assessing disease onset and progression in the SOD1 mouse model of ALS. Papers, record 12802201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12802201
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amyotrophic Lateral Sclerosis | Major topic |
| Disease Models, Animal | Major topic |
| Superoxide Dismutase | Major topic |
| Age of Onset | |
| Animals | |
| Disease Progression | |
| Male | |
| Mice | |
| Mice, Transgenic | |
| Psychomotor Performance |
Source PubMed
Cited by103
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 192 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42883851 | Phenotypic Profiling of SOD1-G93A Mice: Integrating Sciatic Nerve Histopathology with Systemic Chemokine Dynamics During ALS Progression. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42883851 | PubMed |
| 42350385 | Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model. | Nat Commun | 2026 | https://conductscience.org/library/papers/42350385 | PubMed |
| 41213972 | Development of a targeted BioPROTAC degrader selective for misfolded SOD1. | Nat Commun | 2025 | https://conductscience.org/library/papers/41213972 | PubMed |
| 40841608 | An Elongator mouse model of ALS spotlights TDP-43 in the motor neuron nucleolus. | Commun Biol | 2025 | https://conductscience.org/library/papers/40841608 | PubMed |
| 40356623 | Muscle-specific kinase levels in blood are an early diagnostic biomarker for SOD1-93A mouse model of ALS. | Front Neurol | 2025 | https://conductscience.org/library/papers/40356623 | PubMed |
| 39851451 | Enhanced Interleukin 6 Trans-Signaling Modulates Disease Process in Amyotrophic Lateral Sclerosis Mouse Models. | Brain Sci | 2025 | https://conductscience.org/library/papers/39851451 | PubMed |
| 38435120 | Intrathecal administration of a novel siRNA modality extends survival and improves motor function in the SOD1G93A ALS mouse model. | Mol Ther Nucleic Acids | 2024 | https://conductscience.org/library/papers/38435120 | PubMed |
| 38241160 | Nicotinamide riboside, pterostilbene and ibudilast protect motor neurons and extend survival in ALS mice. | Neurotherapeutics | 2024 | https://conductscience.org/library/papers/38241160 | PubMed |
| 37439013 | Potential effects of brain lipid binding protein in the pathogenesis of amyotrophic lateral sclerosis. | Sci Prog | 2023 | https://conductscience.org/library/papers/37439013 | PubMed |
| 37273905 | Development of abnormalities at the neuromuscular junction in the SOD1-G93A mouse model of ALS: dysfunction then disruption of postsynaptic structure precede overt motor symptoms. | Front Mol Neurosci | 2023 | https://conductscience.org/library/papers/37273905 | PubMed |
| 37252191 | Free fatty acids support oligodendrocyte survival in a mouse model of amyotrophic lateral sclerosis. | Front Cell Neurosci | 2023 | https://conductscience.org/library/papers/37252191 | PubMed |
| 37189613 | Oral Treatment with d-RD2RD2 Impedes Early Disease Mechanisms in SOD1*G93A Transgenic Mice but Does Not Prolong Survival. | Biomedicines | 2023 | https://conductscience.org/library/papers/37189613 | PubMed |
| 37049492 | Analysis of Feeding Behavior Characteristics in the Cu/Zn Superoxide Dismutase 1 (SOD1) SOD1G93A Mice Model for Amyotrophic Lateral Sclerosis (ALS). | Nutrients | 2023 | https://conductscience.org/library/papers/37049492 | PubMed |
| 36926731 | 5-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis. | Neural Regen Res | 2023 | https://conductscience.org/library/papers/36926731 | PubMed |
| 36741054 | Comparing therapeutic modulators of the SOD1 G93A Amyotrophic Lateral Sclerosis mouse pathophysiology. | Front Neurosci | 2022 | https://conductscience.org/library/papers/36741054 | PubMed |
| 36619925 | Assessing the therapeutic impact of resveratrol in ALS SOD1-G93A mice with electrical impedance myography. | Front Neurol | 2022 | https://conductscience.org/library/papers/36619925 | PubMed |
| 36531135 | Endothelin-1, over-expressed in SOD1G93A mice, aggravates injury of NSC34-hSOD1G93A cells through complicated molecular mechanism revealed by quantitative proteomics analysis. | Front Cell Neurosci | 2022 | https://conductscience.org/library/papers/36531135 | PubMed |
| 36220871 | A novel assessment of fine-motor function reveals early hindlimb and detectable forelimb deficits in an experimental model of ALS. | Sci Rep | 2022 | https://conductscience.org/library/papers/36220871 | PubMed |
| 36042292 | BL-918, a small-molecule activator of ULK1, induces cytoprotective autophagy for amyotrophic lateral sclerosis therapy. | Acta Pharmacol Sin | 2023 | https://conductscience.org/library/papers/36042292 | PubMed |
| 35328829 | Therapeutic Treatment of Superoxide Dismutase 1 (G93A) Amyotrophic Lateral Sclerosis Model Mice with Medical Ozone Decelerates Trigeminal Motor Neuron Degeneration, Attenuates Microglial Proliferation, and Preserves Monocyte Levels in Mesenteric Lymph Nodes. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35328829 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12802201
GET https://conductscience.org/api/papers/v1/12802201/cited_by?page=2